Neurocrine Biosciences Inc (NBIX): Depreciation & Amortization
Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$4.02M
Year ended 2018-12-31
+58.6%
3-year compound annual growth
+43.1%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2018-12-31 | $4.02M | +67.7% | 2019-02-08, From 2018-01-01 |
| 2017-12-31 | $2.40M | +65.2% | 2019-02-08, From 2017-01-01 |
| 2016-12-31 | $1.45M | +44.0% | 2019-02-08, From 2016-01-01 |
| 2015-12-31 | $1.01M | +22.0% | 2018-02-13, From 2015-01-01 |
| 2014-12-31 | $827.0K | +23.2% | 2017-02-14, From 2014-01-01 |
| 2013-12-31 | $671.0K | +2.1% | 2016-02-11, From 2013-01-01 |
| 2012-12-31 | $657.0K | -5.3% | 2015-02-09, From 2012-01-01 |
| 2011-12-31 | $694.0K | -51.7% | 2014-02-11, From 2011-01-01 |
| 2010-12-31 | $1.44M | -54.8% | 2013-02-08, From 2010-01-01 |
| 2009-12-31 | $3.18M | n/a | 2012-02-09, From 2009-01-01 |